Molecular Pathological Study on Expression of Prb and CDK4，MTS Gene Changes in Human Gliomas

田新华,江澄川,高翔,陈商群,许凯黎,周瑾

DOI: https://doi.org/10.3760/j.issn:1001-2346.2001.01.005

2001-01-01

Abstract:Objective To investigate expression of pRb and CDK4, MTS gene changes in human gliomas and relationship with the clinical pathology. Methods Brain gliomas with different pathologic types were detected by using PCR-SSCP, Southern blot, Slot blot and immunohistochemistry. Results The negative expression of p16 or pRb and CDK4 amplification often occurred independently. The total rate of negative expression of p16 and/or pRb and/or deletion of p15 and/or CDK4 amplification were in 89% (42/47).Conclusions The propensity was occurrence of singular (89%) rather than combined aberrant expression of p16 or pRb or CDK4 amplification. The suppression of p16, p15 or pRb or the increased activity of CDK4 were sufficient to disrupt this regulatory mechanism in a manner that favors cell proliferation and tissues canceration.